Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
Lexicon Pharmaceuticals (NASDAQ: LXRX), a biopharmaceutical company leveraging its proprietary Genome5000™ program to ...09 December, 2019No comment
Canopy Growth (NYSE: CGC), a Canadian cannabis behemoth, announced the launch of a new hemp-derived CBD line for the Ame...05 December, 2019No comment
LiveXLive Media (NASDAQ: LIVX), a global entertainment Company that is engaged in acquisition, distribution and monetiza...04 December, 2019No comment
Profound Medical Corp (NASDAQ: PROF), a medical technology Company that offers magnetic resonance guided ablation proced...02 December, 2019No comment
Holiday season beings cheers to not only consumers but also to Companies, which try to make the most of the season by of...27 November, 2019No comment
Axcella Health (NASDAQ: AXLA), a biotechnology Company focussed on leveraging the power of Endogenous Metabolic Modulato...26 November, 2019No comment
Gout is a form of inflammatory Arthritis caused by high levels of uric acid in the blood, and is characterised by the fo...25 November, 2019No comment
Axovant Gene Therapies (NASDAQ: AXGT) announced the grant of an Orphan Drug Designation for AXO-AAV-GM1, the Company’s...22 November, 2019No comment
Foamix and Menlo Therapeutics have signed a definitive merger agreement to form a biopharmaceutical Company focused on d...21 November, 2019No comment
Sonasoft (OTCQB: SSFT), a pioneer in the AI powered data management solutions space, has launched AURA , the world’s f...20 November, 2019No comment
BYD Company Ltd (OTCPINK: BYDDF), a leading Electric Vehicles Manufacturer, announced a partnership with Toyota Motor Co...18 November, 2019No comment
CV Sciences (OTCQB: CVSI), the manufacturer of PLUSCBD range of hemp-based CBD oils, the #1 selling hemp CBD supplement ...14 November, 2019No comment
Obseva (NASDAQ: OBSV), a biopharmaceutical Company focused on women’s reproductive health announced the discontinuatio...13 November, 2019No comment
Conformis Inc (NASDAQ: CFMS), a medical technology company dealing in Knee and Joint replacements, has announced the cle...12 November, 2019No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.